In keeping with this, we observed increased GLUT1 expression by CAR γδ T cells and a non-significant shift to glucose-dependent metabolism under conditions of tumor re-stimulation, which might underpin the increased effector function. This evidence concerns the gene SLC2A1 and neoplasm.